MELATONIN

MELATONIN was reported 55488 times

MELATONIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 168 0.7368
1 APPENDICOLITH 275 0.7106
2 SLEEP DISORDER THERAPY 112 0.5657
3 ANTACID THERAPY 67 0.5154
4 ANALGESIC THERAPY 116 0.3614
5 DRUG THERAPY 110 0.3245
6 MALIGNANT MELANOMA STAGE 0 66 0.3158
7 ANTICOAGULANT THERAPY 65 0.2289
8 VICTIM OF CHILD ABUSE 48 0.1912
9 CHILD ABUSE 45 0.1737
10 EPIDURAL LIPOMATOSIS 55 0.1599
11 HYPERPHOSPHATAEMIA 160 0.0743
12 BLOOD PHOSPHORUS INCREASED 193 0.0706
13 MALIGNANT MELANOMA IN SITU 86 0.0694
14 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 48 0.0518
15 INFUSION SITE MASS 46 0.0423
16 CLOSTRIDIUM TEST POSITIVE 89 0.0403
17 BREATH SOUNDS ABNORMAL 183 0.0371
18 BENIGN PROSTATIC HYPERPLASIA 189 0.0366
19 INFUSION SITE DISCHARGE 64 0.0365
20 TOTAL LUNG CAPACITY DECREASED 58 0.0363
21 STOMA SITE INFECTION 47 0.0361
22 APPENDICITIS 309 0.0330
23 STOMA SITE ERYTHEMA 58 0.0310
24 BLOOD URIC ACID INCREASED 175 0.0303
25 APLASTIC ANAEMIA 156 0.0298
26 ESSENTIAL HYPERTENSION 53 0.0289
27 IRON DEFICIENCY 127 0.0282
28 SEDATION COMPLICATION 72 0.0282
29 FREEZING PHENOMENON 104 0.0281
30 INTENTIONAL SELF-INJURY 567 0.0280
31 STOMA SITE DISCHARGE 75 0.0274
32 MYASTHENIA GRAVIS 221 0.0273
33 STOMA SITE PAIN 40 0.0272
34 ON AND OFF PHENOMENON 151 0.0272
35 BRONCHIECTASIS 182 0.0270
36 AORTIC STENOSIS 93 0.0267
37 INFUSION SITE HAEMORRHAGE 85 0.0258
38 INFUSION SITE BRUISING 55 0.0254
39 INFUSION SITE PRURITUS 80 0.0253
40 JUVENILE IDIOPATHIC ARTHRITIS 61 0.0249
41 HYPOPHOSPHATAEMIA 177 0.0239
42 VENTRICULAR FIBRILLATION 265 0.0238
43 LUNG OPACITY 62 0.0235
44 INFUSION SITE SWELLING 147 0.0233
45 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 115 0.0227
46 DEVICE INFUSION ISSUE 56 0.0226
47 PRE-EXISTING CONDITION IMPROVED 135 0.0216
48 CARDIOGENIC SHOCK 303 0.0211
49 PLEURITIC PAIN 58 0.0210
50 FULL BLOOD COUNT ABNORMAL 212 0.0200
51 OCULOGYRIC CRISIS 43 0.0200
52 INFUSION SITE INFECTION 46 0.0198
53 BEHAVIOUR DISORDER 107 0.0198
54 INFUSION SITE ERYTHEMA 166 0.0197
55 MICTURITION URGENCY 218 0.0191
56 SLOW SPEECH 46 0.0189
57 PNEUMONIA ASPIRATION 468 0.0187
58 INFUSION SITE PAIN 238 0.0185
59 HYPERPARATHYROIDISM SECONDARY 46 0.0183
60 RHINOVIRUS INFECTION 71 0.0182
61 NEPHROGENIC ANAEMIA 84 0.0181
62 HOSPICE CARE 178 0.0180
63 HYPERVOLAEMIA 89 0.0180
64 HALLUCINATIONS, MIXED 75 0.0178
65 TROPONIN INCREASED 130 0.0171
66 SNORING 64 0.0169
67 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 89 0.0163
68 REBOUND ACID HYPERSECRETION 49 0.0162
69 HYPERCHOLESTEROLAEMIA 156 0.0161
70 DROOLING 110 0.0159
71 CATHETER SITE PAIN 41 0.0158
72 TIC 84 0.0154
73 POSTURE ABNORMAL 50 0.0154
74 HALLUCINATION, VISUAL 321 0.0152
75 SOMNAMBULISM 99 0.0151
76 INITIAL INSOMNIA 154 0.0150
77 NEURALGIA 363 0.0149
78 RESPIRATORY SYMPTOM 42 0.0148
79 MULTIPLE ORGAN DYSFUNCTION SYNDROME 416 0.0147
80 PRODUCT ADMINISTRATION INTERRUPTED 115 0.0146
81 PARADOXICAL DRUG REACTION 53 0.0144
82 ANAL INCONTINENCE 129 0.0143
83 ELECTRIC SHOCK SENSATION 40 0.0143
84 BRADYKINESIA 84 0.0142
85 DELUSION 220 0.0141
86 ASCITES 416 0.0141
87 SEASONAL ALLERGY 194 0.0137
88 SLEEP APNOEA SYNDROME 260 0.0136
89 IMPULSIVE BEHAVIOUR 51 0.0136
90 RESPIRATORY DEPRESSION 165 0.0134
91 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 228 0.0133
92 HYPERLIPIDAEMIA 158 0.0132
93 HALLUCINATION 996 0.0132
94 BACTERIAL INFECTION 243 0.0130
95 SUICIDAL BEHAVIOUR 54 0.0130
96 ASPIRATION 140 0.0128
97 JOINT INJURY 273 0.0128
98 END STAGE RENAL DISEASE 233 0.0128
99 RESTLESS LEGS SYNDROME 230 0.0126
100 NONSPECIFIC REACTION 69 0.0126
101 SCREAMING 78 0.0122
102 SKIN LACERATION 133 0.0122
103 INTENTIONAL OVERDOSE 782 0.0122
104 REHABILITATION THERAPY 47 0.0121
105 OBSTRUCTIVE AIRWAYS DISORDER 135 0.0121
106 POOR QUALITY SLEEP 261 0.0121
107 INCONTINENCE 128 0.0121
108 SKIN ABRASION 57 0.0120
109 DYSKINESIA 490 0.0120
110 DECUBITUS ULCER 98 0.0120
111 RED CELL DISTRIBUTION WIDTH INCREASED 49 0.0118
112 CARBOHYDRATE ANTIGEN 125 INCREASED 40 0.0117
113 ENURESIS 47 0.0116
114 HAEMOGLOBIN INCREASED 53 0.0116
115 CATATONIA 61 0.0116
116 ACUTE RESPIRATORY FAILURE 222 0.0115
117 DEVICE KINK 42 0.0115
118 ONYCHOCLASIS 79 0.0115
119 PSYCHOMOTOR HYPERACTIVITY 189 0.0114
120 HANGOVER 40 0.0114
121 GENERALISED TONIC-CLONIC SEIZURE 187 0.0113
122 CHRONIC SINUSITIS 42 0.0112
123 EYE MOVEMENT DISORDER 76 0.0111
124 BLOOD CALCIUM INCREASED 97 0.0110
125 GASTROOESOPHAGEAL REFLUX DISEASE 881 0.0109
126 SALIVARY HYPERSECRETION 108 0.0108
127 SLEEP DISORDER 755 0.0107
128 HUMERUS FRACTURE 51 0.0106
129 MIDDLE INSOMNIA 197 0.0105
130 SCOLIOSIS 65 0.0105
131 HYPERNATRAEMIA 52 0.0104
132 CONCUSSION 80 0.0103
133 HYPERSOMNIA 293 0.0102
134 FAILURE TO THRIVE 53 0.0102
135 HYPONATRAEMIA 575 0.0102
136 MUSCLE RIGIDITY 122 0.0102
137 BRAIN FOG 158 0.0101
138 HYPERPHAGIA 40 0.0100
139 SPINAL OSTEOARTHRITIS 88 0.0100
140 OBSTRUCTION 40 0.0100
141 SELF-INJURIOUS IDEATION 42 0.0100
142 AGGRESSION 500 0.0100
143 SOMNOLENCE 1982 0.0098
144 MULTIPLE ALLERGIES 77 0.0098
145 SEIZURE 1132 0.0098
146 VASCULAR DEVICE INFECTION 44 0.0097
147 SPINAL STENOSIS 40 0.0097
148 ESCHERICHIA URINARY TRACT INFECTION 41 0.0096
149 DERMATITIS CONTACT 110 0.0096
150 INSOMNIA 2564 0.0096
151 MENTAL STATUS CHANGES 267 0.0096
152 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 498 0.0095
153 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40 0.0095
154 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 57 0.0094
155 GOUT 168 0.0094
156 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
157 OBSESSIVE-COMPULSIVE DISORDER 75 0.0093
158 RESTLESSNESS 342 0.0093
159 ABNORMAL BEHAVIOUR 370 0.0093
160 AGITATION 681 0.0093
161 AKATHISIA 126 0.0092
162 IRON DEFICIENCY ANAEMIA 85 0.0092
163 PETIT MAL EPILEPSY 47 0.0092
164 APPETITE DISORDER 61 0.0092
165 GASTROENTERITIS VIRAL 166 0.0092
166 RESPIRATORY SYNCYTIAL VIRUS INFECTION 80 0.0092
167 POST-TRAUMATIC STRESS DISORDER 61 0.0091
168 COMA 433 0.0091
169 BRUXISM 49 0.0091
170 EAR INFECTION 241 0.0090
171 CONSTIPATION 1967 0.0090
172 INFUSION SITE EXTRAVASATION 56 0.0090
173 DYSPNOEA EXERTIONAL 338 0.0090
174 DIZZINESS POSTURAL 87 0.0090
175 RALES 52 0.0089
176 SEROTONIN SYNDROME 172 0.0089
177 TENDERNESS 93 0.0089
178 DEVICE OCCLUSION 125 0.0089
179 ORTHOSTATIC HYPOTENSION 153 0.0088
180 PARTIAL SEIZURES 46 0.0088
181 NOCTURIA 106 0.0087
182 PARKINSONISM 85 0.0087
183 TRANSIENT ISCHAEMIC ATTACK 292 0.0086
184 PRODUCTIVE COUGH 413 0.0086
185 DECREASED INTEREST 51 0.0086
186 BLOOD TEST ABNORMAL 121 0.0086
187 POOR VENOUS ACCESS 89 0.0086
188 OBESITY 137 0.0086
189 NEUTROPHIL COUNT INCREASED 88 0.0086
190 COGNITIVE DISORDER 401 0.0086
191 SPUTUM DISCOLOURED 81 0.0085
192 HYPOXIA 299 0.0085
193 CYSTIC FIBROSIS 47 0.0085
194 CLOSTRIDIUM DIFFICILE COLITIS 90 0.0085
195 PARANOIA 146 0.0085
196 ELECTROCARDIOGRAM ABNORMAL 66 0.0084
197 HYPOPHAGIA 215 0.0084
198 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 43 0.0084
199 BALANCE DISORDER 724 0.0084
200 UNRESPONSIVE TO STIMULI 216 0.0084
201 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 399 0.0083
202 PRODUCT DISTRIBUTION ISSUE 77 0.0083
203 SINUS BRADYCARDIA 80 0.0083
204 PRODUCT PRESCRIBING ERROR 197 0.0083
205 AFFECTIVE DISORDER 65 0.0083
206 HEPATIC CYTOLYSIS 105 0.0082
207 ULCER 131 0.0082
208 IMPAIRED GASTRIC EMPTYING 112 0.0082
209 COVID-19 PNEUMONIA 97 0.0082
210 WEIGHT FLUCTUATION 85 0.0081
211 MUSCLE TIGHTNESS 131 0.0081
212 DIABETIC NEUROPATHY 40 0.0081
213 UPPER RESPIRATORY TRACT INFECTION 373 0.0081
214 DYSARTHRIA 303 0.0080
215 FOOD ALLERGY 62 0.0080
216 MYOCARDITIS 92 0.0080
217 HALLUCINATION, AUDITORY 127 0.0080
218 AUTISM SPECTRUM DISORDER 44 0.0080
219 INSURANCE ISSUE 122 0.0080
220 SUICIDAL IDEATION 730 0.0080
221 ENERGY INCREASED 47 0.0080
222 DELIRIUM 276 0.0079
223 MUSCLE TWITCHING 183 0.0079
224 HYPOKINESIA 115 0.0079
225 BLOOD CHOLESTEROL INCREASED 368 0.0079
226 MYDRIASIS 101 0.0079
227 DYSTONIA 152 0.0078
228 BOWEL MOVEMENT IRREGULARITY 60 0.0078
229 DRY MOUTH 635 0.0078
230 CONFUSIONAL STATE 1263 0.0078
231 FRUSTRATION TOLERANCE DECREASED 63 0.0078
232 PRODUCT PREPARATION ISSUE 51 0.0078
233 SEDATION 203 0.0077
234 DEMENTIA 216 0.0077
235 PELVIC FRACTURE 60 0.0077
236 GASTROINTESTINAL MOTILITY DISORDER 41 0.0077
237 EXERCISE TOLERANCE DECREASED 44 0.0076
238 ABDOMINAL DISTENSION 798 0.0076
239 DISTURBANCE IN ATTENTION 410 0.0076
240 URINARY INCONTINENCE 225 0.0076
241 THINKING ABNORMAL 141 0.0076
242 TRANSFUSION 79 0.0075
243 FALL 2496 0.0075
244 URINARY TRACT INFECTION 1274 0.0075
245 ABNORMAL DREAMS 206 0.0075
246 BLOOD PRESSURE FLUCTUATION 179 0.0074
247 INTERVERTEBRAL DISC DEGENERATION 69 0.0074
248 FEELING DRUNK 55 0.0074
249 SINUS TACHYCARDIA 105 0.0074
250 LIVER FUNCTION TEST INCREASED 158 0.0074
251 HIATUS HERNIA 95 0.0073
252 POLYURIA 60 0.0073
253 SMALL INTESTINAL OBSTRUCTION 90 0.0073
254 MENTAL IMPAIRMENT 177 0.0073
255 HEAD INJURY 231 0.0073
256 OXYGEN SATURATION DECREASED 410 0.0073
257 TREMOR 1210 0.0073
258 CLOSTRIDIUM DIFFICILE INFECTION 159 0.0073
259 POISONING DELIBERATE 69 0.0073
260 ANGER 246 0.0073
261 SEPSIS 811 0.0073
262 MOTOR DYSFUNCTION 74 0.0073
263 HYPERKERATOSIS 40 0.0072
264 PULMONARY MASS 108 0.0072
265 HYPERVENTILATION 42 0.0072
266 MALNUTRITION 81 0.0072
267 PANIC ATTACK 262 0.0072
268 VITAMIN D DEFICIENCY 70 0.0072
269 MUSCLE STRAIN 62 0.0072
270 CARPAL TUNNEL SYNDROME 100 0.0071
271 PERIPHERAL COLDNESS 98 0.0071
272 THERAPY CHANGE 70 0.0071
273 PSYCHOTIC DISORDER 210 0.0071
274 SPEECH DISORDER 371 0.0071
275 NIGHTMARE 245 0.0071
276 CORONARY ARTERY DISEASE 213 0.0070
277 RED BLOOD CELL COUNT DECREASED 201 0.0070
278 HYPOVOLAEMIA 41 0.0070
279 EATING DISORDER 149 0.0070
280 CRYING 254 0.0070
281 MAJOR DEPRESSION 51 0.0070
282 INCREASED APPETITE 133 0.0070
283 RIB FRACTURE 143 0.0069
284 PHARYNGITIS STREPTOCOCCAL 75 0.0069
285 DYSSTASIA 201 0.0069
286 BRAIN INJURY 69 0.0069
287 TERMINAL STATE 46 0.0069
288 RESPIRATORY TRACT CONGESTION 109 0.0069
289 IRRITABILITY 412 0.0068
290 ABNORMAL FAECES 56 0.0068
291 SCRATCH 72 0.0068
292 WALKING AID USER 45 0.0068
293 SINUS DISORDER 135 0.0068
294 BLOOD PRESSURE ABNORMAL 135 0.0068
295 GINGIVAL PAIN 54 0.0068
296 DISSOCIATION 52 0.0068
297 PAIN IN JAW 192 0.0068
298 HAND FRACTURE 48 0.0068
299 GLUCOSE TOLERANCE IMPAIRED 40 0.0068
300 AFFECT LABILITY 65 0.0067
301 INCREASED TENDENCY TO BRUISE 62 0.0067
302 RETCHING 143 0.0067
303 INTENTIONAL DOSE OMISSION 191 0.0067
304 LETHARGY 385 0.0067
305 DENTAL CARIES 74 0.0067
306 SINUSITIS 681 0.0066
307 INCOHERENT 43 0.0066
308 GAIT INABILITY 222 0.0066
309 URINE OUTPUT DECREASED 58 0.0066
310 LYMPHOCYTE COUNT DECREASED 117 0.0066
311 VIRAL INFECTION 220 0.0066
312 COMPLICATION ASSOCIATED WITH DEVICE 96 0.0066
313 HEAD DISCOMFORT 117 0.0066
314 CHRONIC KIDNEY DISEASE 500 0.0066
315 APHTHOUS ULCER 51 0.0066
316 CONTUSION 629 0.0065
317 ORAL CANDIDIASIS 86 0.0065
318 ENCEPHALOPATHY 160 0.0065
319 UROSEPSIS 60 0.0065
320 OCULAR DISCOMFORT 73 0.0065
321 TEMPERATURE INTOLERANCE 67 0.0065
322 BLOOD IRON DECREASED 77 0.0065
323 BEDRIDDEN 85 0.0065
324 BLOOD PRESSURE SYSTOLIC INCREASED 126 0.0065
325 MANIA 106 0.0064
326 HIP FRACTURE 207 0.0064
327 RIGHT VENTRICULAR FAILURE 45 0.0064
328 LIMB INJURY 174 0.0064
329 HUNGER 89 0.0064
330 BLOOD SODIUM DECREASED 120 0.0064
331 ANXIETY 1811 0.0064
332 FEELING JITTERY 121 0.0063
333 PRODUCT USE COMPLAINT 100 0.0063
334 ARTHROPOD BITE 47 0.0063
335 SENSORY LOSS 51 0.0063
336 DEPRESSED MOOD 334 0.0063
337 CYANOSIS 99 0.0063
338 STATUS EPILEPTICUS 71 0.0063
339 SUICIDE ATTEMPT 381 0.0063
340 NECK PAIN 350 0.0063
341 BLOOD MAGNESIUM DECREASED 54 0.0063
342 BIPOLAR DISORDER 68 0.0062
343 BLOOD POTASSIUM DECREASED 188 0.0062
344 NEPHROLITHIASIS 286 0.0062
345 BACTERAEMIA 74 0.0062
346 URINARY RETENTION 208 0.0062
347 APHASIA 188 0.0062
348 VITAMIN D DECREASED 53 0.0062
349 GENERAL PHYSICAL HEALTH DETERIORATION 717 0.0062
350 FEBRILE NEUTROPENIA 411 0.0062
351 TOOTH ABSCESS 63 0.0062
352 INTENTIONAL UNDERDOSE 45 0.0062
353 SECRETION DISCHARGE 77 0.0061
354 SINUS CONGESTION 83 0.0061
355 EYE PAIN 346 0.0061
356 MUSCULAR WEAKNESS 695 0.0061
357 BACK DISORDER 99 0.0061
358 RESPIRATORY RATE INCREASED 54 0.0061
359 METASTASES TO LYMPH NODES 41 0.0061
360 DEPRESSION 1382 0.0061
361 NERVE COMPRESSION 56 0.0061
362 NASAL CONGESTION 355 0.0060
363 CELLULITIS 304 0.0060
364 MUSCLE ATROPHY 76 0.0060
365 OSTEOPENIA 91 0.0060
366 TOOTH INFECTION 79 0.0060
367 TOOTH FRACTURE 66 0.0060
368 ATAXIA 71 0.0060
369 DISORIENTATION 237 0.0060
370 LIGAMENT SPRAIN 59 0.0060
371 HEREDITARY ANGIOEDEMA 64 0.0060
372 BLOOD PRESSURE DIASTOLIC DECREASED 44 0.0060
373 JOINT DISLOCATION 63 0.0060
374 RESPIRATORY TRACT INFECTION 155 0.0059
375 MEMORY IMPAIRMENT 815 0.0059
376 ACUTE KIDNEY INJURY 904 0.0059
377 GAIT DISTURBANCE 1126 0.0059
378 LIMB DISCOMFORT 182 0.0059
379 MUSCULOSKELETAL CHEST PAIN 91 0.0059
380 FLUID RETENTION 299 0.0059
381 OROPHARYNGEAL DISCOMFORT 53 0.0059
382 PULMONARY ARTERIAL HYPERTENSION 85 0.0059
383 TASTE DISORDER 119 0.0059
384 HEART RATE INCREASED 581 0.0059
385 FATIGUE 4565 0.0059
386 POLLAKIURIA 244 0.0058
387 DYSPHAGIA 554 0.0058
388 NIGHT SWEATS 188 0.0058
389 DECREASED APPETITE 1355 0.0058
390 SCIATICA 93 0.0058
391 TACHYCARDIA 518 0.0058
392 INTENTIONAL PRODUCT MISUSE 510 0.0058
393 PANIC REACTION 42 0.0058
394 FEEDING DISORDER 118 0.0058
395 BLOOD COUNT ABNORMAL 88 0.0058
396 COLD SWEAT 102 0.0058
397 HOT FLUSH 436 0.0058
398 SLUGGISHNESS 59 0.0058
399 HEART RATE DECREASED 203 0.0058
400 PNEUMONIA BACTERIAL 53 0.0058
401 BURSITIS 70 0.0058
402 MUSCULOSKELETAL STIFFNESS 505 0.0058
403 INTERVERTEBRAL DISC PROTRUSION 126 0.0058
404 FORMICATION 40 0.0057
405 DEPRESSED LEVEL OF CONSCIOUSNESS 227 0.0057
406 TINNITUS 263 0.0057
407 SKIN INFECTION 64 0.0057
408 HYPOAESTHESIA ORAL 86 0.0057
409 EXOSTOSIS 52 0.0057
410 GROIN PAIN 50 0.0057
411 SENSITIVE SKIN 42 0.0057
412 CHOLECYSTECTOMY 65 0.0057
413 RESPIRATORY DISTRESS 157 0.0057
414 CYTOKINE RELEASE SYNDROME 114 0.0057
415 BLOOD ALBUMIN DECREASED 45 0.0057
416 PLEURAL EFFUSION 345 0.0057
417 NEUROPATHY PERIPHERAL 539 0.0057
418 RENAL CYST 45 0.0057
419 HEART RATE IRREGULAR 128 0.0057
420 EUPHORIC MOOD 58 0.0057
421 DRUG INTERACTION 898 0.0057
422 WHITE BLOOD CELL COUNT INCREASED 217 0.0057
423 WEIGHT DECREASED 1576 0.0056
424 CANDIDA INFECTION 95 0.0056
425 BRONCHITIS 416 0.0056
426 EAR PAIN 109 0.0056
427 RHINORRHOEA 362 0.0056
428 ESCHERICHIA INFECTION 46 0.0056
429 ATELECTASIS 54 0.0056
430 CHOKING 109 0.0056
431 COVID-19 979 0.0056
432 GASTROINTESTINAL INFECTION 50 0.0056
433 NERVE INJURY 62 0.0056
434 MOVEMENT DISORDER 179 0.0056
435 EPISTAXIS 417 0.0056
436 FLATULENCE 316 0.0056
437 TUMOUR LYSIS SYNDROME 49 0.0056
438 MIGRAINE 531 0.0056
439 ELECTROCARDIOGRAM QT PROLONGED 200 0.0056
440 CEREBRAL DISORDER 41 0.0055
441 INFLUENZA 618 0.0055
442 MUSCLE SPASTICITY 68 0.0055
443 WEIGHT INCREASED 1237 0.0055
444 THROMBOSIS 443 0.0055
445 MOOD ALTERED 150 0.0055
446 PERSONALITY CHANGE 51 0.0055
447 THERAPEUTIC RESPONSE UNEXPECTED 246 0.0055
448 PRESCRIBED OVERDOSE 106 0.0055
449 DECREASED ACTIVITY 59 0.0055
450 DIPLOPIA 142 0.0055
451 MUSCULOSKELETAL DISORDER 104 0.0055
452 FEELING COLD 152 0.0055
453 ROTATOR CUFF SYNDROME 70 0.0054
454 SWELLING 510 0.0054
455 HAEMOPTYSIS 152 0.0054
456 PNEUMONIA 1760 0.0054
457 PAROSMIA 41 0.0054
458 SUPRAVENTRICULAR TACHYCARDIA 52 0.0054
459 BLOOD URINE PRESENT 103 0.0054
460 MENTAL DISORDER 235 0.0054
461 FACIAL PARALYSIS 46 0.0054
462 HAEMATOCRIT DECREASED 107 0.0054
463 PRODUCT DOSE OMISSION ISSUE 1586 0.0054
464 ABDOMINAL PAIN 1254 0.0054
465 OROPHARYNGEAL PAIN 498 0.0054
466 HYPERTHERMIA 41 0.0054
467 DEVICE PHYSICAL PROPERTY ISSUE 41 0.0053
468 DRY EYE 267 0.0053
469 MUSCULOSKELETAL DISCOMFORT 92 0.0053
470 FLANK PAIN 50 0.0053
471 CONDITION AGGRAVATED 1617 0.0053
472 THIRST 95 0.0053
473 PHOTOPHOBIA 100 0.0053
474 MOBILITY DECREASED 382 0.0053
475 ORAL PAIN 119 0.0053
476 EYE INFECTION 60 0.0053
477 WHEEZING 315 0.0053
478 NEUROLEPTIC MALIGNANT SYNDROME 63 0.0053
479 COUGH 1489 0.0053
480 ASTHENIA 1996 0.0053
481 AMNESIA 345 0.0053
482 MUSCLE SPASMS 973 0.0053
483 DEHYDRATION 707 0.0053
484 ILLNESS 546 0.0053
485 IMMUNODEFICIENCY 79 0.0053
486 QUALITY OF LIFE DECREASED 71 0.0053
487 SPINAL OPERATION 65 0.0053
488 FOOT FRACTURE 100 0.0053
489 DYSURIA 194 0.0053
490 UPPER LIMB FRACTURE 105 0.0053
491 FIBROMYALGIA 128 0.0053
492 PERIPHERAL SWELLING 811 0.0053
493 ATRIAL FLUTTER 42 0.0053
494 BLOOD TRIGLYCERIDES INCREASED 93 0.0053
495 LOCALISED INFECTION 127 0.0052
496 ASPARTATE AMINOTRANSFERASE INCREASED 278 0.0052
497 PRODUCT DOSE OMISSION IN ERROR 148 0.0052
498 NASOPHARYNGITIS 963 0.0052
499 TACHYPNOEA 71 0.0052
500 HYPOKALAEMIA 241 0.0052
501 APATHY 76 0.0052
502 CARDIAC MURMUR 45 0.0052
503 MYOCLONUS 62 0.0052
504 DEVICE RELATED INFECTION 80 0.0052
505 HYPOTENSION 1038 0.0052
506 OEDEMA 280 0.0052
507 COORDINATION ABNORMAL 72 0.0052
508 CYST 64 0.0052
509 EXTRAPYRAMIDAL DISORDER 128 0.0051
510 BACK INJURY 56 0.0051
511 HYPERTENSION 1090 0.0051
512 TOOTHACHE 93 0.0051
513 BLOOD PRESSURE INCREASED 785 0.0051
514 CYSTITIS 163 0.0051
515 JOINT STIFFNESS 134 0.0051
516 ORAL HERPES 99 0.0051
517 FEELING ABNORMAL 1213 0.0051
518 FULL BLOOD COUNT DECREASED 102 0.0051
519 BACK PAIN 1173 0.0050
520 MITRAL VALVE INCOMPETENCE 57 0.0050
521 PRESCRIBED UNDERDOSE 100 0.0050
522 DYSPHONIA 293 0.0050
523 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
524 FEELING HOT 305 0.0050
525 GLOMERULAR FILTRATION RATE DECREASED 61 0.0050
526 DRUG LEVEL DECREASED 50 0.0049
527 VENTRICULAR EXTRASYSTOLES 51 0.0049
528 ERUCTATION 95 0.0049
529 FUNGAL INFECTION 163 0.0049
530 VOMITING 2298 0.0049
531 HEADACHE 3061 0.0049
532 STOMATITIS 296 0.0049
533 COLITIS 185 0.0049
534 PRODUCT AVAILABILITY ISSUE 111 0.0049
535 NAUSEA 3858 0.0049
536 EMOTIONAL DISORDER 150 0.0049
537 LEUKOCYTOSIS 88 0.0049
538 THROAT IRRITATION 218 0.0049
539 DRUG INTOLERANCE 469 0.0049
540 PRESYNCOPE 118 0.0048
541 METABOLIC ACIDOSIS 155 0.0048
542 RESPIRATORY FAILURE 353 0.0048
543 BLADDER DISORDER 48 0.0048
544 THERAPY CESSATION 248 0.0048
545 GASTROINTESTINAL PAIN 53 0.0048
546 DIARRHOEA HAEMORRHAGIC 45 0.0048
547 DIZZINESS 2399 0.0048
548 DIARRHOEA 3101 0.0048
549 THYROID DISORDER 74 0.0048
550 FAECES DISCOLOURED 104 0.0048
551 SKIN HAEMORRHAGE 71 0.0048
552 BLOOD CREATININE INCREASED 312 0.0048
553 INTENTIONAL PRODUCT USE ISSUE 418 0.0048
554 PULMONARY THROMBOSIS 52 0.0048
555 ATRIAL FIBRILLATION 464 0.0048
556 DIVERTICULITIS 132 0.0048
557 STAPHYLOCOCCAL INFECTION 157 0.0048
558 OEDEMA PERIPHERAL 580 0.0048
559 PERICARDIAL EFFUSION 110 0.0048
560 METASTASES TO LIVER 83 0.0047
561 FEAR 127 0.0047
562 ANKLE FRACTURE 73 0.0047
563 EYE DISCHARGE 49 0.0047
564 TENDONITIS 73 0.0047
565 MOOD SWINGS 150 0.0047
566 LOWER RESPIRATORY TRACT INFECTION 214 0.0047
567 DYSPNOEA 2653 0.0047
568 SNEEZING 105 0.0047
569 BLOOD POTASSIUM INCREASED 76 0.0047
570 NEUROTOXICITY 82 0.0047
571 TOOTH DISORDER 104 0.0047
572 ARTERIOSCLEROSIS 44 0.0047
573 THERAPEUTIC RESPONSE SHORTENED 155 0.0047
574 PNEUMOTHORAX 74 0.0047
575 DYSPEPSIA 459 0.0047
576 IMPAIRED QUALITY OF LIFE 67 0.0047
577 DRUG EFFECT LESS THAN EXPECTED 69 0.0047
578 BODY TEMPERATURE INCREASED 95 0.0047
579 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 331 0.0046
580 WITHDRAWAL SYNDROME 195 0.0046
581 PRODUCT SUBSTITUTION ISSUE 267 0.0046
582 HYPOTHYROIDISM 148 0.0046
583 PURPURA 41 0.0046
584 SUBDURAL HAEMATOMA 66 0.0046
585 ALANINE AMINOTRANSFERASE INCREASED 283 0.0046
586 FOOT DEFORMITY 51 0.0046
587 DEVICE DISLOCATION 200 0.0046
588 ANAEMIA 876 0.0046
589 FACIAL PAIN 41 0.0046
590 TRANSAMINASES INCREASED 102 0.0046
591 BODY HEIGHT DECREASED 49 0.0046
592 HEPATIC STEATOSIS 85 0.0046
593 PULMONARY CONGESTION 60 0.0045
594 SARS-COV-2 TEST POSITIVE 60 0.0045
595 LOSS OF CONSCIOUSNESS 582 0.0045
596 SPINAL FRACTURE 91 0.0045
597 SPINAL DISORDER 43 0.0045
598 HYPERHIDROSIS 584 0.0045
599 EYELID PTOSIS 46 0.0045
600 GASTROINTESTINAL DISORDER 404 0.0045
601 PULMONARY EMBOLISM 428 0.0045
602 WHITE BLOOD CELL COUNT DECREASED 488 0.0045
603 ASTHMA 508 0.0045
604 IMPAIRED WORK ABILITY 96 0.0045
605 HAEMOGLOBIN DECREASED 461 0.0045
606 LUNG DISORDER 220 0.0045
607 INTESTINAL OBSTRUCTION 169 0.0045
608 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
609 IRRITABLE BOWEL SYNDROME 96 0.0045
610 IMMUNE SYSTEM DISORDER 59 0.0045
611 VITREOUS FLOATERS 44 0.0045
612 BONE PAIN 262 0.0045
613 PAIN IN EXTREMITY 1315 0.0045
614 HERNIA 86 0.0044
615 HYPOTHERMIA 45 0.0044
616 SPLENOMEGALY 52 0.0044
617 BLOOD PRESSURE DECREASED 294 0.0044
618 WRIST FRACTURE 53 0.0044
619 VISION BLURRED 607 0.0044
620 LYMPHADENOPATHY 156 0.0044
621 DIABETES MELLITUS 335 0.0044
622 MUCOSAL INFLAMMATION 115 0.0044
623 OSTEOARTHRITIS 186 0.0044
624 CARDIAC ARREST 362 0.0044
625 WOUND INFECTION 48 0.0044
626 PLATELET COUNT DECREASED 467 0.0044
627 HYPOAESTHESIA 655 0.0044
628 HEPATOMEGALY 43 0.0044
629 LOWER LIMB FRACTURE 84 0.0044
630 HEPATIC ENZYME INCREASED 298 0.0044
631 NODULE 57 0.0044
632 CENTRAL NERVOUS SYSTEM LESION 60 0.0044
633 PARAESTHESIA 685 0.0043
634 DRUG LEVEL INCREASED 72 0.0043
635 SEXUAL DYSFUNCTION 51 0.0043
636 SKIN FISSURES 85 0.0043
637 ABDOMINAL DISCOMFORT 729 0.0043
638 PALLOR 118 0.0043
639 KIDNEY INFECTION 85 0.0043
640 DRY THROAT 44 0.0043
641 HOSPITALISATION 663 0.0043
642 INFUSION RELATED REACTION 286 0.0043
643 AUTOIMMUNE DISORDER 42 0.0043
644 BLOOD UREA INCREASED 72 0.0043
645 PHOTOSENSITIVITY REACTION 71 0.0043
646 ABDOMINAL PAIN UPPER 885 0.0043
647 NERVOUSNESS 224 0.0043
648 PALPITATIONS 502 0.0043
649 GENERALISED OEDEMA 53 0.0043
650 HERPES ZOSTER 246 0.0043
651 PULMONARY HYPERTENSION 89 0.0043
652 UNEVALUABLE EVENT 322 0.0043
653 HAEMORRHOIDS 83 0.0043
654 CHEST PAIN 788 0.0043
655 LACERATION 40 0.0042
656 CATARACT 252 0.0042
657 OSTEOPOROSIS 174 0.0042
658 RASH PRURITIC 229 0.0042
659 IMPAIRED DRIVING ABILITY 48 0.0042
660 VERTIGO 257 0.0042
661 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 758 0.0042
662 ALTERED STATE OF CONSCIOUSNESS 91 0.0042
663 EAR DISCOMFORT 43 0.0042
664 GASTRITIS 110 0.0042
665 SENSORY DISTURBANCE 67 0.0042
666 KNEE OPERATION 41 0.0042
667 PRODUCT DOSE OMISSION 272 0.0042
668 POST PROCEDURAL COMPLICATION 80 0.0042
669 CHROMATURIA 94 0.0042
670 EPILEPSY 127 0.0042
671 MYALGIA 704 0.0041
672 FLUSHING 419 0.0041
673 ADRENAL INSUFFICIENCY 50 0.0041
674 CHOLESTASIS 79 0.0041
675 RESPIRATORY DISORDER 123 0.0041
676 ROAD TRAFFIC ACCIDENT 172 0.0041
677 PRODUCT USE IN UNAPPROVED INDICATION 1018 0.0041
678 BLOOD ALKALINE PHOSPHATASE INCREASED 102 0.0041
679 HYPOTONIA 41 0.0041
680 ORAL DISCOMFORT 57 0.0041
681 HAIR COLOUR CHANGES 51 0.0041
682 CONTRAINDICATED PRODUCT ADMINISTERED 124 0.0041
683 SURGERY 240 0.0041
684 OSTEOMYELITIS 74 0.0041
685 APHONIA 57 0.0041
686 BODY TEMPERATURE DECREASED 40 0.0041
687 BRADYCARDIA 215 0.0040
688 SKIN DISCOLOURATION 186 0.0040
689 OFF LABEL USE 3541 0.0040
690 CHILLS 474 0.0040
691 COMPLETED SUICIDE 336 0.0040
692 GINGIVAL BLEEDING 55 0.0040
693 THERAPY NON-RESPONDER 181 0.0040
694 CHOLELITHIASIS 131 0.0040
695 FLUID OVERLOAD 58 0.0040
696 SYNCOPE 398 0.0040
697 THERAPY PARTIAL RESPONDER 62 0.0040
698 LACRIMATION INCREASED 120 0.0040
699 ELECTROLYTE IMBALANCE 46 0.0040
700 RASH MACULO-PAPULAR 88 0.0040
701 ILEUS 49 0.0039
702 PAIN 2422 0.0039
703 OESOPHAGITIS 43 0.0039
704 MASS 55 0.0039
705 TARDIVE DYSKINESIA 111 0.0039
706 THERAPY INTERRUPTED 281 0.0039
707 ARTHRALGIA 1631 0.0039
708 PYREXIA 1355 0.0039
709 BLOOD CALCIUM DECREASED 44 0.0039
710 PLATELET COUNT INCREASED 51 0.0039
711 INFECTION 564 0.0039
712 HYPERCALCAEMIA 48 0.0039
713 MENSTRUATION DELAYED 42 0.0039
714 CHEST DISCOMFORT 396 0.0039
715 PRODUCT ADMINISTRATION ERROR 78 0.0039
716 ANHEDONIA 101 0.0038
717 RASH PAPULAR 86 0.0038
718 PHARYNGEAL OEDEMA 59 0.0038
719 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 65 0.0038
720 ARTHRITIS 301 0.0038
721 PROCEDURAL PAIN 106 0.0038
722 PARAESTHESIA ORAL 55 0.0038
723 UNDERDOSE 278 0.0038
724 PRODUCT USE ISSUE 715 0.0038
725 BRAIN OEDEMA 48 0.0038
726 PARALYSIS 54 0.0038
727 SCAB 43 0.0038
728 ECONOMIC PROBLEM 57 0.0038
729 SPINAL PAIN 44 0.0038
730 THERAPEUTIC PRODUCT EFFECT DECREASED 168 0.0037
731 WOUND 104 0.0037
732 SKIN DISORDER 124 0.0037
733 TOOTH EXTRACTION 46 0.0037
734 RASH MACULAR 129 0.0037
735 DEVICE ISSUE 330 0.0037
736 SEPTIC SHOCK 160 0.0037
737 RENAL FAILURE 488 0.0037
738 NERVOUS SYSTEM DISORDER 114 0.0036
739 HYPERKALAEMIA 128 0.0036
740 SKIN LESION 100 0.0036
741 GLAUCOMA 70 0.0036
742 OCULAR HYPERAEMIA 171 0.0036
743 LABORATORY TEST ABNORMAL 106 0.0036
744 FREQUENT BOWEL MOVEMENTS 97 0.0036
745 INTERNAL HAEMORRHAGE 41 0.0036
746 HAEMATOCHEZIA 198 0.0036
747 RHABDOMYOLYSIS 149 0.0036
748 PNEUMONITIS 97 0.0036
749 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 195 0.0036
750 EJECTION FRACTION DECREASED 55 0.0035
751 HYPOACUSIS 152 0.0035
752 TREATMENT NONCOMPLIANCE 193 0.0035
753 RENAL INJURY 104 0.0035
754 MALAISE 1535 0.0035
755 CARDIAC FAILURE CONGESTIVE 281 0.0035
756 VISUAL IMPAIRMENT 433 0.0035
757 SKIN CANCER 75 0.0035
758 NEOPLASM 40 0.0035
759 GASTRIC ULCER 66 0.0035
760 NEEDLE ISSUE 101 0.0035
761 HIP ARTHROPLASTY 53 0.0035
762 NEUTROPHIL COUNT DECREASED 141 0.0035
763 BLISTER 194 0.0035
764 PRURITUS 1326 0.0034
765 HYPOMAGNESAEMIA 48 0.0034
766 THROAT TIGHTNESS 93 0.0034
767 HEMIPARESIS 58 0.0034
768 PRODUCT PHYSICAL ISSUE 69 0.0034
769 MUSCULOSKELETAL PAIN 179 0.0034
770 INFLUENZA LIKE ILLNESS 281 0.0034
771 PANCYTOPENIA 190 0.0034
772 EYE PRURITUS 114 0.0034
773 HYPERTHYROIDISM 49 0.0034
774 PANCREATITIS ACUTE 76 0.0034
775 DYSGEUSIA 251 0.0034
776 PULMONARY OEDEMA 151 0.0034
777 BLOOD BILIRUBIN INCREASED 91 0.0034
778 HAIR TEXTURE ABNORMAL 45 0.0034
779 HEPATIC CIRRHOSIS 63 0.0033
780 MACULAR DEGENERATION 40 0.0033
781 MULTIPLE SCLEROSIS 160 0.0033
782 PLASMA CELL MYELOMA 130 0.0033
783 SKIN ULCER 86 0.0033
784 KNEE ARTHROPLASTY 70 0.0033
785 MOUTH ULCERATION 70 0.0033
786 ABSCESS 53 0.0033
787 METASTASES TO BONE 54 0.0033
788 MALIGNANT MELANOMA 44 0.0033
789 INCORRECT PRODUCT ADMINISTRATION DURATION 71 0.0033
790 SCAR 56 0.0033
791 BASAL CELL CARCINOMA 51 0.0033
792 ALOPECIA 637 0.0032
793 ABDOMINAL PAIN LOWER 82 0.0032
794 TENDON RUPTURE 40 0.0032
795 BURNING SENSATION 227 0.0032
796 RECTAL HAEMORRHAGE 139 0.0032
797 DEVICE FAILURE 49 0.0032
798 C-REACTIVE PROTEIN INCREASED 117 0.0032
799 DISEASE PROGRESSION 379 0.0032
800 CONJUNCTIVITIS 59 0.0032
801 HYPOCALCAEMIA 60 0.0032
802 DYSMENORRHOEA 42 0.0032
803 ARTHROPATHY 176 0.0032
804 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70 0.0032
805 DEEP VEIN THROMBOSIS 204 0.0031
806 LIVER DISORDER 139 0.0031
807 SWELLING FACE 204 0.0031
808 FEMUR FRACTURE 97 0.0031
809 LIP SWELLING 104 0.0031
810 JOINT SWELLING 376 0.0031
811 IMPAIRED HEALING 102 0.0031
812 PRODUCT TASTE ABNORMAL 42 0.0031
813 RASH ERYTHEMATOUS 148 0.0031
814 TUBULOINTERSTITIAL NEPHRITIS 58 0.0031
815 SOPOR 41 0.0031
816 MULTIPLE SCLEROSIS RELAPSE 212 0.0031
817 PULMONARY FIBROSIS 59 0.0031
818 RASH 1332 0.0031
819 DRUG ABUSE 254 0.0030
820 DISABILITY 60 0.0030
821 CARDIOVASCULAR DISORDER 77 0.0030
822 DEVICE USE ISSUE 53 0.0030
823 VENTRICULAR TACHYCARDIA 50 0.0030
824 SKIN EXFOLIATION 255 0.0030
825 NEOPLASM PROGRESSION 105 0.0030
826 ADVERSE DRUG REACTION 270 0.0030
827 EYE IRRITATION 173 0.0030
828 DERMATITIS ATOPIC 158 0.0030
829 GLOSSODYNIA 67 0.0030
830 CARDIOMYOPATHY 44 0.0030
831 PROSTATIC SPECIFIC ANTIGEN INCREASED 41 0.0030
832 HAEMATOMA 77 0.0030
833 RENAL DISORDER 138 0.0030
834 HAEMATURIA 101 0.0029
835 GASTRIC DISORDER 101 0.0029
836 CARDIAC FAILURE 236 0.0029
837 UPPER GASTROINTESTINAL HAEMORRHAGE 49 0.0029
838 INFLAMMATION 150 0.0029
839 AGRANULOCYTOSIS 54 0.0029
840 HYPERSENSITIVITY 539 0.0029
841 RENAL IMPAIRMENT 243 0.0029
842 ECZEMA 151 0.0029
843 COAGULOPATHY 48 0.0029
844 ILL-DEFINED DISORDER 175 0.0029
845 GASTROENTERITIS 42 0.0029
846 GASTROINTESTINAL HAEMORRHAGE 240 0.0029
847 DEAFNESS 75 0.0029
848 THROMBOCYTOPENIA 319 0.0028
849 SWOLLEN TONGUE 89 0.0028
850 AGEUSIA 71 0.0028
851 ACCIDENTAL OVERDOSE 104 0.0028
852 URTICARIA 476 0.0028
853 DISCOMFORT 173 0.0028
854 CARDIAC DISORDER 265 0.0028
855 DRY SKIN 378 0.0028
856 HEPATOTOXICITY 63 0.0028
857 EYE DISORDER 93 0.0028
858 EYE SWELLING 105 0.0028
859 HEPATOCELLULAR INJURY 40 0.0028
860 TOXICITY TO VARIOUS AGENTS 472 0.0028
861 ANGINA PECTORIS 80 0.0028
862 MALIGNANT NEOPLASM PROGRESSION 283 0.0028
863 BLOOD GLUCOSE ABNORMAL 51 0.0028
864 ERYTHEMA 565 0.0027
865 DEVICE LEAKAGE 119 0.0027
866 HAEMORRHAGE INTRACRANIAL 41 0.0027
867 PRODUCT PRESCRIBING ISSUE 59 0.0027
868 STEVENS-JOHNSON SYNDROME 60 0.0027
869 DRUG-INDUCED LIVER INJURY 84 0.0027
870 HYPERGLYCAEMIA 97 0.0027
871 CEREBRAL HAEMORRHAGE 95 0.0027
872 TOOTH LOSS 55 0.0027
873 DISEASE RECURRENCE 126 0.0026
874 PELVIC PAIN 48 0.0026
875 LUNG INFECTION 41 0.0026
876 GALLBLADDER DISORDER 47 0.0026
877 ACTIVITIES OF DAILY LIVING IMPAIRED 52 0.0026
878 NEUTROPENIA 356 0.0026
879 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
880 TYPE 2 DIABETES MELLITUS 88 0.0026
881 DEATH 2238 0.0026
882 PANCREATITIS 137 0.0026
883 DEVICE BREAKAGE 105 0.0026
884 INJECTION SITE URTICARIA 63 0.0026
885 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 66 0.0026
886 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 517 0.0025
887 RESPIRATORY ARREST 70 0.0025
888 BONE DISORDER 46 0.0025
889 APPLICATION SITE ERYTHEMA 66 0.0025
890 DRUG INEFFECTIVE 3313 0.0025
891 ACNE 188 0.0025
892 DRUG EFFECT INCOMPLETE 90 0.0025
893 LIVER FUNCTION TEST ABNORMAL 72 0.0025
894 ARRHYTHMIA 117 0.0025
895 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
896 ERECTILE DYSFUNCTION 63 0.0025
897 DRUG PRESCRIBING ERROR 47 0.0024
898 LACTIC ACIDOSIS 79 0.0024
899 SHOCK 56 0.0024
900 INJECTION SITE MASS 90 0.0024
901 INJECTION SITE BRUISING 194 0.0024
902 PRODUCT QUALITY ISSUE 328 0.0024
903 EXPIRED PRODUCT ADMINISTERED 80 0.0024
904 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 56 0.0024
905 CEREBROVASCULAR ACCIDENT 401 0.0024
906 PROTEINURIA 45 0.0024
907 BLOOD GLUCOSE DECREASED 112 0.0023
908 CARDIO-RESPIRATORY ARREST 97 0.0023
909 ABASIA 57 0.0023
910 HAEMATEMESIS 58 0.0023
911 HAEMORRHAGE 238 0.0023
912 ACUTE RESPIRATORY DISTRESS SYNDROME 40 0.0023
913 APPLICATION SITE PRURITUS 51 0.0022
914 ANAPHYLACTIC REACTION 124 0.0022
915 DERMATITIS 47 0.0022
916 PRODUCT PREPARATION ERROR 46 0.0022
917 PAIN OF SKIN 60 0.0022
918 INJECTION SITE PRURITUS 149 0.0022
919 OVERDOSE 478 0.0022
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
921 EXTRA DOSE ADMINISTERED 88 0.0022
922 INJURY 152 0.0022
923 LEUKOPENIA 107 0.0021
924 INCORRECT DOSE ADMINISTERED 486 0.0021
925 THERAPEUTIC RESPONSE DECREASED 129 0.0021
926 HYPOGLYCAEMIA 103 0.0021
927 PSORIATIC ARTHROPATHY 86 0.0021
928 SKIN BURNING SENSATION 151 0.0021
929 ACUTE MYOCARDIAL INFARCTION 62 0.0021
930 DRUG DOSE OMISSION 346 0.0021
931 INJECTION SITE REACTION 144 0.0021
932 INJECTION SITE RASH 64 0.0021
933 DIABETIC KETOACIDOSIS 50 0.0021
934 COLITIS ULCERATIVE 93 0.0021
935 EXPOSURE VIA SKIN CONTACT 53 0.0020
936 PRODUCT ADHESION ISSUE 73 0.0020
937 DRUG EFFECT DECREASED 110 0.0020
938 HEPATIC FAILURE 61 0.0020
939 EMOTIONAL DISTRESS 241 0.0020
940 PRURITUS GENERALISED 43 0.0020
941 PRODUCT DISPENSING ERROR 43 0.0020
942 BLINDNESS 80 0.0020
943 INJECTION SITE WARMTH 40 0.0019
944 LIVER INJURY 47 0.0019
945 ADVERSE EVENT 176 0.0019
946 MELAENA 42 0.0019
947 DRUG ADMINISTRATION ERROR 58 0.0019
948 INJECTION SITE PAIN 578 0.0019
949 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 134 0.0019
950 BONE DENSITY DECREASED 59 0.0019
951 CONVULSION 107 0.0019
952 DRUG WITHDRAWAL SYNDROME 164 0.0019
953 INJECTION SITE SWELLING 143 0.0019
954 APPLICATION SITE PAIN 41 0.0019
955 SYSTEMIC LUPUS ERYTHEMATOSUS 66 0.0019
956 BLOOD GLUCOSE INCREASED 348 0.0018
957 JAUNDICE 49 0.0018
958 SKIN IRRITATION 82 0.0018
959 RHEUMATOID ARTHRITIS 203 0.0018
960 VAGINAL HAEMORRHAGE 77 0.0018
961 INCORRECT DOSE ADMINISTERED BY DEVICE 46 0.0018
962 WRONG TECHNIQUE IN DRUG USAGE PROCESS 63 0.0017
963 INJECTION SITE ERYTHEMA 215 0.0017
964 PSORIASIS 226 0.0017
965 INJECTION SITE HAEMORRHAGE 135 0.0017
966 NO ADVERSE EVENT 303 0.0017
967 HEPATITIS 42 0.0016
968 CEREBRAL INFARCTION 40 0.0016
969 DRUG DEPENDENCE 257 0.0016
970 NEOPLASM MALIGNANT 106 0.0016
971 ANGIOEDEMA 69 0.0016
972 DEVICE MALFUNCTION 109 0.0015
973 MEDICATION ERROR 85 0.0015
974 TREATMENT FAILURE 120 0.0014
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67 0.0014
976 INCORRECT DRUG ADMINISTRATION DURATION 40 0.0014
977 VISUAL ACUITY REDUCED 47 0.0014
978 MYOCARDIAL INFARCTION 235 0.0013
979 DEVICE USE ERROR 46 0.0013
980 EXPOSURE DURING PREGNANCY 78 0.0013
981 INTERSTITIAL LUNG DISEASE 59 0.0012
982 DEVICE DIFFICULT TO USE 75 0.0011
983 LUNG NEOPLASM MALIGNANT 46 0.0011
984 PRODUCT STORAGE ERROR 96 0.0011
985 ABORTION SPONTANEOUS 41 0.0010
986 ACCIDENTAL EXPOSURE TO PRODUCT 100 0.0010
987 MATERNAL EXPOSURE DURING PREGNANCY 80 0.0009
988 BREAST CANCER 69 0.0007
989 PROSTATE CANCER 55 0.0007
990 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
991 DRUG DOSE OMISSION BY DEVICE 49 0.0006